Latest Regulatory Approval News

Impact Minerals has acquired a 55 sq km tenement covering the historic Huonville gold district near Broken Hill, significantly expanding its landholding and advancing its exploration for copper-gold deposits.

Anteris Technologies has completed a $90 million strategic investment from Medtronic as part of a $320 million capital raise, advancing its DurAVR transcatheter heart valve towards global commercialisation and pivotal clinical trials.

Anteris Technologies has closed a $320 million capital raise, combining a $230 million public offering and a strategic private placement with Medtronic, to advance its DurAVR heart valve clinical trials and manufacturing growth.

Light & Wonder, Inc. has amended its credit agreement to introduce a new $2.13 billion tranche of term loans due in 2029, replacing prior debt and reducing borrowing costs. The move reflects a strategic refinancing amid its Nasdaq delisting process.

Rox Resources has confirmed the economic viability of its Youanmi Gold Project with a robust feasibility study and commenced underground mining, backed by a $218 million equity raise. The company is on track for first gold production by mid-2027.

Anteris Technologies Global Corp. has launched a $230 million equity offering alongside an $84 million private placement with Medtronic’s subsidiary, aiming to accelerate clinical trials and scale manufacturing of its innovative DurAVR Transcatheter Heart Valve.

Memphasys Limited has achieved its first material revenues following CE Mark approval for its Felix™ System, activating multi-year contracts across Europe, the Middle East, and Asia. The company is now transitioning from regulatory preparation to global commercial rollout with a focus on recurring revenues.

Gold Mountain Limited has agreed to sell its Papua New Guinea exploration licences for $2 million, redirecting funds to advance its promising Brazilian projects and strengthen working capital.

LTR Pharma has initiated dosing in its Phase II clinical trial for SPONTAN, a rapid-acting intranasal spray targeting erectile dysfunction, marking a key step toward FDA approval and commercial expansion.

1414 Degrees updates on the administration of its joint venture partner Vast Solar Aurora, exploring acquisition options while progressing key renewable projects. The company also advances its October 2025 placement with shareholder-approved options now moving towards ASX quotation.

Infini Resources has completed a significant Phase 2 drilling campaign at its Portland Creek Uranium Project, alongside a strategic landholding expansion exceeding 120%, while confirming high-grade uranium at other Canadian projects.

Amplitude Energy has reported record quarterly production and revenue for Q2 FY26, alongside a dramatic reduction in net debt and the commencement of drilling for its East Coast Supply Project.